{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:48:50Z","timestamp":1777034930845,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10529-021-03115-z","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T22:02:38Z","timestamp":1617314558000},"page":"1357-1369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["MiR-103\/miR-107 inhibits enterovirus 71 replication and facilitates type I interferon response by regulating SOCS3\/STAT3 pathway"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8014-3882","authenticated-orcid":false,"given":"Baizhi","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"3115_CR1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05005","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. eLife. https:\/\/doi.org\/10.7554\/eLife.05005","journal-title":"eLife"},{"issue":"6","key":"3115_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nri818","volume":"2","author":"WS Alexander","year":"2002","unstructured":"Alexander WS (2002) Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2(6):410\u2013416","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"3115_CR3","first-page":"161","volume":"2","author":"AM Ardekani","year":"2010","unstructured":"Ardekani AM, Naeini MM (2010) The role of microRNAs in human diseases. Avicenna J Med Biotechnol 2(4):161","journal-title":"Avicenna J Med Biotechnol"},{"issue":"9","key":"3115_CR4","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/ijerph13090890","volume":"13","author":"PC Chang","year":"2016","unstructured":"Chang PC, Chen SC, Chen KT (2016) The current status of the disease caused by enterovirus 71 infections: epidemiology, pathogenesis, molecular epidemiology, and vaccine development. Int J Environ Res Public Health 13(9):890","journal-title":"Int J Environ Res Public Health"},{"key":"3115_CR5","doi-asserted-by":"publisher","DOI":"10.3201\/eid2101.140992","author":"S Chea","year":"2015","unstructured":"Chea S et al (2015) Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia. Emerg Infect Dis. https:\/\/doi.org\/10.3201\/eid2101.140992","journal-title":"Emerg Infect Dis"},{"issue":"28","key":"3115_CR6","doi-asserted-by":"publisher","first-page":"14706","DOI":"10.1074\/jbc.M115.700252","volume":"291","author":"L Chen","year":"2016","unstructured":"Chen L et al (2016) MicroRNA-223 promotes type I interferon production in antiviral innate immunity by targeting forkhead box protein O3 (FOXO3). J Biol Chem 291(28):14706\u201314716","journal-title":"J Biol Chem"},{"issue":"1","key":"3115_CR7","doi-asserted-by":"publisher","first-page":"9687","DOI":"10.1038\/s41598-019-41053-z","volume":"9","author":"HY Chen","year":"2019","unstructured":"Chen HY et al (2019) miR-103\/107 prolong Wnt\/\u03b2-catenin signaling and colorectal cancer stemness by targeting Axin2. Sci Rep 9(1):9687","journal-title":"Sci Rep"},{"key":"3115_CR8","doi-asserted-by":"publisher","first-page":"13476","DOI":"10.1038\/ncomms13476","volume":"7","author":"D Chmiest","year":"2016","unstructured":"Chmiest D et al (2016) Spatiotemporal control of interferon-induced JAK\/STAT signalling and gene transcription by the retromer complex. Nat Commun 7:13476","journal-title":"Nat Commun"},{"key":"3115_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.lfs.2016.01.043","volume":"147","author":"B Deng","year":"2016","unstructured":"Deng B et al (2016) MicroRNA-103\/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1\u03b2. Life Sci 147:117\u2013124","journal-title":"Life Sci"},{"issue":"5","key":"3115_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.tips.2019.03.001","volume":"40","author":"GA Durham","year":"2019","unstructured":"Durham GA, Williams JJL, Nasim MT, Palmer TM (2019) Targeting SOCS proteins to control JAK-STAT signalling in disease. Trends Pharmacol Sci 40(5):298\u2013308","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"3115_CR11","first-page":"236","volume":"14","author":"K Felekkis","year":"2010","unstructured":"Felekkis K, Touvana E, Stefanou C, Deltas C (2010) microRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia 14(4):236","journal-title":"Hippokratia"},{"key":"3115_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.virusres.2017.05.008","volume":"237","author":"N Feng","year":"2017","unstructured":"Feng N et al (2017) Enterovirus 71-induced has-miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. Virus Res 237:27\u201336","journal-title":"Virus Res"},{"key":"3115_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fimmu.2015.00334","volume":"6","author":"SC Forster","year":"2015","unstructured":"Forster SC, Tate MD, Hertzog PJ (2015) MicroRNA as type I interferon-regulated transcripts and modulators of the innate immune response. Front Immunol 6:334","journal-title":"Front Immunol"},{"key":"3115_CR14","first-page":"2430640","volume":"2020","author":"W Gao","year":"2020","unstructured":"Gao W, Hou M, Liu X, Li Z, Yang Y, Zhang W (2020) Induction of SOCS expression by EV71 infection promotes EV71 replication. Biomed Res Int 2020:2430640","journal-title":"Biomed Res Int"},{"key":"3115_CR15","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1038\/ncomms4344","volume":"5","author":"BC Ho","year":"2014","unstructured":"Ho BC et al (2014) Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun 5:3344","journal-title":"Nat Commun"},{"key":"3115_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virusres.2015.02.003","volume":"209","author":"MJ Killip","year":"2015","unstructured":"Killip MJ, Fodor E, Randall RE (2015) Influenza virus activation of the interferon system. Virus Res 209:11\u201322","journal-title":"Virus Res"},{"issue":"1\u20132","key":"3115_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.virusres.2009.12.003","volume":"148","author":"B Koeberlein","year":"2010","unstructured":"Koeberlein B et al (2010) Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Res 148(1\u20132):51\u201359","journal-title":"Virus Res"},{"issue":"2","key":"3115_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s11262-014-1035-2","volume":"48","author":"Y Liu","year":"2014","unstructured":"Liu Y et al (2014) A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China. Virus Genes 48(2):260\u2013272","journal-title":"Virus Genes"},{"issue":"17","key":"3115_CR19","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00018-016-2234-x","volume":"73","author":"R Mahony","year":"2016","unstructured":"Mahony R, Ahmed S, Diskin C, Stevenson NJ (2016) SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use? Cell Mol Life Sci 73(17):3323\u20133336","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"3115_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab F, Mayer-Barber K, Sher A, Wack A, O\u2019Garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15(2):87\u2013103","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"3115_CR21","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/eji.201041198","volume":"41","author":"RC Miller","year":"2011","unstructured":"Miller RC et al (2011) HIV interferes with SOCS-1 and -3 expression levels driving immune activation. Eur J Immunol 41(4):1058\u20131069","journal-title":"Eur J Immunol"},{"issue":"8","key":"3115_CR22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/1753425918803674","volume":"24","author":"NV Nguyen","year":"2018","unstructured":"Nguyen NV, Tran JT, Sanchez DJ (2018) HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation. Innate Immun 24(8):490\u2013500","journal-title":"Innate Immun"},{"issue":"5","key":"3115_CR23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bpa.12279","volume":"25","author":"KC Ong","year":"2015","unstructured":"Ong KC, Wong KT (2015) Understanding Enterovirus 71 neuropathogenesis and its impact on other neurotropic enteroviruses. Brain Pathol 25(5):614\u2013624","journal-title":"Brain Pathol"},{"issue":"11","key":"3115_CR24","doi-asserted-by":"publisher","first-page":"e1000196","DOI":"10.1371\/journal.ppat.1000196","volume":"4","author":"EK Pauli","year":"2008","unstructured":"Pauli EK et al (2008) Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 4(11):e1000196","journal-title":"PLoS Pathog"},{"issue":"3","key":"3115_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.it.2015.02.002","volume":"36","author":"RA Porritt","year":"2015","unstructured":"Porritt RA, Hertzog PJ (2015) Dynamic control of type I IFN signalling by an integrated network of negative regulators. Trends Immunol 36(3):150\u2013160","journal-title":"Trends Immunol"},{"issue":"14","key":"3115_CR26","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s00018-017-2520-2","volume":"74","author":"N Raftery","year":"2017","unstructured":"Raftery N, Stevenson NJ (2017) Advances in anti-viral immune defence: revealing the importance of the IFN JAK\/STAT pathway. Cell Mol Life Sci 74(14):2525\u20132535","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3115_CR27","doi-asserted-by":"publisher","first-page":"e2016","DOI":"10.1002\/rmv.2016","volume":"29","author":"M Rasti","year":"2019","unstructured":"Rasti M, Khanbabaei H, Teimoori A (2019) An update on enterovirus 71 infection and interferon type I response. Rev Med Virol 29(1):e2016","journal-title":"Rev Med Virol"},{"issue":"7","key":"3115_CR28","first-page":"408","volume":"100","author":"A Saguil","year":"2019","unstructured":"Saguil A, Kane SF, Lauters R, Mercado MG (2019) Hand-foot-and-mouth disease: rapid evidence review. Am Fam Phys 100(7):408\u2013414","journal-title":"Am Fam Phys"},{"issue":"3","key":"3115_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.it.2015.01.002","volume":"36","author":"G Schreiber","year":"2015","unstructured":"Schreiber G, Piehler J (2015) The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol 36(3):139\u2013149","journal-title":"Trends Immunol"},{"key":"3115_CR30","first-page":"298","volume":"26","author":"M Stanic","year":"1963","unstructured":"Stanic M (1963) A simplification of the estimation of the 50 percent endpoints according to the Reed and Muench method. Pathol Microbiol (Basel) 26:298\u2013302","journal-title":"Pathol Microbiol (Basel)"},{"issue":"6","key":"3115_CR31","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.4049\/jimmunol.1402794","volume":"194","author":"SA Stifter","year":"2015","unstructured":"Stifter SA, Feng CG (2015) Interfering with immunity: detrimental role of type I IFNs during infection. J Immunol 194(6):2455\u20132465","journal-title":"J Immunol"},{"issue":"8","key":"3115_CR32","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1128\/JVI.03101-14","volume":"89","author":"M Strauss","year":"2015","unstructured":"Strauss M, Filman DJ, Belnap DM, Cheng N, Noel RT, Hogle JM (2015) Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry. J Virol 89(8):4143\u20134157","journal-title":"J Virol"},{"issue":"3","key":"3115_CR33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.bbrc.2004.06.051","volume":"320","author":"G Vlotides","year":"2004","unstructured":"Vlotides G et al (2004) SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. Biochem Biophys Res Commun 320(3):1007\u20131014","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3115_CR34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/CIRCRESAHA.117.305781","volume":"117","author":"JX Wang","year":"2015","unstructured":"Wang JX et al (2015) MicroRNA-103\/107 regulate programmed necrosis and myocardial ischemia\/reperfusion injury through targeting FADD. Circ Res 117(4):352\u2013363","journal-title":"Circ Res"},{"issue":"4","key":"3115_CR35","doi-asserted-by":"publisher","first-page":"e95272","DOI":"10.1371\/journal.pone.0095272","volume":"9","author":"LJ Xu","year":"2014","unstructured":"Xu LJ et al (2014) Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression. PLoS ONE 9(4):e95272","journal-title":"PLoS ONE"},{"issue":"2","key":"3115_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/15384101.2019.1704512","volume":"19","author":"D Yang","year":"2020","unstructured":"Yang D, Wang X, Gao H, Chen B, Si C, Wang S (2020) Downregulation of miR-155-5p facilitates enterovirus 71 replication through suppression of type I IFN response by targeting FOXO3\/IRF7 pathway. Cell Cycle 19(2):179\u2013192","journal-title":"Cell Cycle"},{"issue":"4","key":"3115_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.bbrc.2017.03.109","volume":"488","author":"K Yu","year":"2017","unstructured":"Yu K et al (2017) MicroRNA-548j inhibits type I interferon production by targeting ZBTB11 in patients with chronic hepatitis B. Biochem Biophys Res Commun 488(4):628\u2013633","journal-title":"Biochem Biophys Res Commun"},{"issue":"24","key":"3115_CR38","first-page":"8616","volume":"22","author":"QF Yu","year":"2018","unstructured":"Yu QF et al (2018) MiR-103\/107 induces tumorigenicity in bladder cancer cell by suppressing PTEN. Eur Rev Med Pharmacol Sci 22(24):8616\u20138623","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"3115_CR39","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1128\/JVI.02655-12","volume":"87","author":"Z Zheng","year":"2013","unstructured":"Zheng Z et al (2013) Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol 87(10):5645\u20135656","journal-title":"J Virol"},{"key":"3115_CR40","first-page":"4302470","volume":"2016","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Qi Y, Fan H, Cui L, Shi Z (2016) Systematic identification and bioinformatic analysis of MicroRNAs in response to infections of coxsackievirus A16 and enterovirus 71. Biomed Res Int 2016:4302470","journal-title":"Biomed Res Int"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-021-03115-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10529-021-03115-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-021-03115-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:55:58Z","timestamp":1659059758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10529-021-03115-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3115"],"URL":"https:\/\/doi.org\/10.1007\/s10529-021-03115-z","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"value":"0141-5492","type":"print"},{"value":"1573-6776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"27 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The design of this protocol follows the tenets of the Declaration of Helsinki, approved by the Ethics Committee of Binhaiwan Central Hospital of Dongguan.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}